Drug Profile
Droxicam
Alternative Names: Dobenam; Droflex; Drogelon; Droxar; E 3128; Ferpan; PrecamLatest Information Update: 29 Apr 2003
Price :
$50
*
At a glance
- Originator Esteve
- Developer Almirall-Prodesfarma; Angelini Group; Esteve; Johnson & Johnson
- Class Antirheumatics; Nonsteroidal anti-inflammatories; Pyridines; Small molecules
- Mechanism of Action Prostaglandin synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Market Withdrawal Rheumatic disorders
Most Recent Events
- 16 Apr 2003 Pharmacia Corporation has been acquired by, and merged into, Pfizer
- 05 Apr 2000 Pharmacia & Upjohn has merged with Monsanto to form Pharmacia Corporation
- 01 Sep 1995 Launched for Rheumatic disorders in Pakistan (PO)